J7121 HCPCS code: 5% dextrose in lactated ringers infusion, up to 1000 cc
J7121 is the HCPCS Level II code for 5% dextrose in lactated ringers infusion, up to 1000 cc. In 2024 Medicare paid an average of $4.19 per service for J7121 across 150 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 5 per day on outpatient hospital claims. Medicare volume fell 16% from 2022 to 2024 (179 to 150 services). In 2024, about 45 clinicians billed Medicare for J7121 for 100 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2016-01-01 |
| Last action effective | 2016-01-01 |
Who bills J7121 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 45 |
| Medicare beneficiaries | 100 |
| States with claims | 3 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7121, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 179 | 82 | $4.08 | $3.09 |
| 2023 | 272 | 111 | $4.32 | $3.40 |
| 2024 | 150 | 100 | $5.68 | $4.19 |
States with the most J7121 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 43 | $4.14 |
| California | 36 | $5.89 |
| Kansas | 19 | $4.41 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 5 | Clinical: Data |
| practitioner claims | 4 | Clinical: CMS Workgroup |
What changed for J7121
- 2016-01-01: J7121 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7121?
J7121 is the HCPCS Level II code for 5% dextrose in lactated ringers infusion, up to 1000 cc. Short descriptor: "5% dextrose in lac ringers".
How much does Medicare pay for J7121?
In 2024, the average Medicare payment was $4.19 per service (average allowed $5.68).
Does Medicare cover J7121?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J7121 can be billed per day?
5 on outpatient hospital claims; 4 on practitioner claims (NCCI medically unlikely edits).
Related J71 codes
- J7100 — Infusion, dextran 40, 500 ml
- J7110 — Infusion, dextran 75, 500 ml
- J7120 — Ringers lactate infusion, up to 1000 cc
- J7131 — Hypertonic saline solution, 1 ml
- J7165 — Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
- J7168 — Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- J7169 — Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
- J7170 — Injection, emicizumab-kxwh, 0.5 mg
- J7171 — Injection, adamts13, recombinant-krhn, 10 iu
- J7172 — Injection, marstacimab-hncq, 0.5 mg
- J7173 — Injection, concizumab-mtci, 0.5 mg
- J7174 — Injection, fitusiran, 0.04 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7121
- Watch J7121 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7121
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.